Compare Nasdaq Inc (NDAQ) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq Inc vs ResMed Inc. — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while ResMed Inc. trades at $196 (market cap $28.81B). The key difference: Nasdaq Inc is the larger of the two by market cap, and Nasdaq Inc pays the higher dividend (1.22%). Which is the better fit depends on your goals.
| NDAQ | RMD | |
|---|---|---|
Market Cap | $51.96B | $28.81B |
Sector | Financials | Health |
52-Week High | $100.98 | $293.73 |
52-Week Low | $76.85 | $182.82 |
Enterprise Value | $59.02B | $27.99B |
Dividend Yield | 1.22% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
